Page last updated: 2024-08-21

alpha-aminopyridine and Musculoskeletal Diseases

alpha-aminopyridine has been researched along with Musculoskeletal Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bradbury, P; Jodrell, DI; Talbot, DC; Wall, L1
Mueller-Schwefe, G2
Aigner, M; Herrmann, WM; Hiersemenzel, R; Lobisch, M; Michel, I; Riethmüller-Winzen, H1

Trials

3 trial(s) available for alpha-aminopyridine and Musculoskeletal Diseases

ArticleYear
A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours.
    British journal of cancer, 2004, Feb-23, Volume: 90, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aminopyridines; Drug Administration Schedule; Female; Humans; Hydroxamic Acids; Male; Maximum Tolerated Dose; Metalloendopeptidases; Middle Aged; Musculoskeletal Diseases; Neoplasms; Treatment Outcome

2004
[Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study].
    Fortschritte der Medizin. Originalien, 2003, Volume: 121, Issue:1

    Topics: Acute Disease; Adult; Aged; Aminopyridines; Analgesics; Back Pain; Chronic Disease; Facial Pain; Female; Follow-Up Studies; Humans; Male; Middle Aged; Musculoskeletal Diseases; Neck Pain; Pain Measurement; Quality of Life; Spasm; Sprains and Strains; Tension-Type Headache

2003
[Long-term tolerance of flupirtine. Open multicenter study over one year].
    Fortschritte der Medizin, 1993, May-30, Volume: 111, Issue:15

    Topics: Adult; Aged; Aminopyridines; Analgesics; Chronic Disease; Female; Humans; Long-Term Care; Male; Middle Aged; Musculoskeletal Diseases; Pain; Pain Measurement

1993

Other Studies

1 other study(ies) available for alpha-aminopyridine and Musculoskeletal Diseases

ArticleYear
[Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study].
    MMW Fortschritte der Medizin, 2003, Mar-10, Volume: 145, Issue:12

    Topics: Aminopyridines; Analgesics; Humans; Musculoskeletal Diseases; Neuroprotective Agents; Pain; Pain Measurement; Treatment Outcome

2003